Annual / Quarterly Financial Statement • Oct 23, 2022
Annual / Quarterly Financial Statement
Open in ViewerOpens in native device viewer
Amsterdam, the Netherlands
Report on the Financial Statements for 2021
In thousands of EUROS
Report on the financial statements 2021
| Management report | 3 |
|---|---|
| Balance Sheet as at 31 December 2021 |
4 |
| Profit and Loss Account for the period from the year 2021 | 5 |
| Statment of changes in Equity | 6-7 |
| Notes to the financial statements for 2021 |
8-14 |
Report on the financial statements 2021
Report on the financial statements 2021
Section 2:396(7) of the Netherlands Civil Code provides an exemption with respect to the preparation and inclusion of a management report as part of the financial statements.
| December 31, | ||||
|---|---|---|---|---|
| 2021 | 2020 | |||
| Euros in thousands | ||||
| Non-current assets: |
||||
| Investment in investees | 308,985 | 197,882 | ||
| Deferred taxes | 73 | 590 | ||
| 309,058 | 198,472 | |||
| Current assets: | ||||
| Cash and cash equivalents | 18,917 | 32,194 | ||
| Cash in trust | 15,159 | |||
| Other receivables | 94 | 373 | ||
| Financial assets | - | 853 | ||
| 34,170 | 33,420 | |||
| Total assets | 343,228 | 231,892 | ||
| Equity | ||||
| Share Capital | 181 | 151 | ||
| Premium on Shares | 221,012 | 171,076 | ||
| Share based payment capital reserve | 1,650 | 263 | ||
| Legal reserve subsidiairies | 110,652 | 55,602 | ||
| Retained earnings | 8,530 | 4,748 | ||
| 342,025 | 231,840 | |||
| Current Liabilities | ||||
| Accounts payable | 1,203 | 52 | ||
| Total equity and liabilities | 343,228 | 231,892 |
| Year ended December 31, 2021 |
Year ended December 31, 2020 |
||
|---|---|---|---|
| Euros in thousands |
Euros in thousands |
||
| Administrative and general expenses | (1,206) | )1,027( | |
| Financial income (expenses) | 2,350 | )1,464( | |
| Taxes | (517) | 192 | |
| Equity in earnings of investee's | 58,205 | 24,961 | |
| Net income | 58,832 | 22,662 |
| Year ended December 31, 2021 | |||||||
|---|---|---|---|---|---|---|---|
| Equity attributable to equity holders of the Company | |||||||
| Share capital |
Share premium |
Legal reserve subsidaries |
Share based payment capital reserve |
Retained earnings |
Total attributable to equity holders of the Company |
||
| Euros in thousands | |||||||
| Balance as of January 1, 2021 | 151 | 171,076 | 55,602 | 263 | 4,748 | 231,840 | |
| Issuances of share capital, net | 30 | 49,936 | - | - | - | 49,966 | |
| Net and comprehensive income | - | - | - | - | 58,832 | 58,832 | |
| Classification in accordance with Dutch law |
- | - | 55,050 | - | )55,050( | - | |
| Cost of share based payment | - | - | - | 1,387 | - | 1,387 | |
| Balance as of December 31, 2021 | 181 | 221,012 | 110,652 | 1,650 | 8,530 | 342,025 |
Report on the financial statements 2021
| Year ended December 31, 2020 Equity attributable to equity holders of the Company |
||||||
|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Legal reserve subsidiai ries |
Share base payments capital reserve |
Retained earnings |
Total attributable to equity holders of the Company |
|
| Euros in thousands | ||||||
| Balance as of January 1, 2020 | 12,064 | 116,672 | 35,808 | - | 1,880 | 166,424 |
| Capital conversion to premium | )11,992( | 11,992 | - | - | - | - |
| Issuances of shares, net | 79 | 42,412 | - | - | - | 42,491 |
| Total net and comprehensive income | - | - | - | - | 22,662 | 22,662 |
| Classification in accordance with Dutch law | - | - | 19,794 | - | (19,794) | - |
| Cost of share based payment | - | - | - | 263 | - | 263 |
| Balance as of December 31, 2020 | 151 | 171,076 | 55,602 | 263 | 4,748 | 231,840 |
ARGO Properties N.V. ("the Company") was incorporated on January 25, 2018 and is a Dutchbased real estate company engaging via investees in the acquisition and management of investment properties in Germany, mainly in the area of income-generating commercial and income-generating residential real estate.
The financial statements cover the accounting year of the company for 2021.
The financial statements have been prepared in accordance with Title 9, Book 2 of the Netherlands Civil Code and the firm pronunciations of the Dutch Accounting Standards Board (RJ).
The company has opted not to prepare consolidated financial statements, making use of the exemption provided under section 2:407 of the Netherlands Civil Code.
These financial statements have been prepared on the basis of the going concern principle.
The principles applied for the valuation of assets and liabilities and result determination are based on the historical cost convention.
Unless stated otherwise, assets and liabilities are carried at nominal value.
An asset is disclosed in the balance sheet when it is probable that the expected future economic benefits that are attributable to the asset will flow to the entity and the value can be measured reliably. A liability is recognised in the balance sheet when it is expected to result in an outflow from the entity of resources embodying economic benefits and the amount of the obligation can be measured with sufficient reliability.
Income is recognised in the profit and loss account when an increase in future economic potential related to an increase in an asset or a decrease in a liability has arisen, the size of which can be measured reliably. Expenses are recognised when a decrease in the economic potential related to a decrease in an asset or an increase in a liability has arisen, the size of which can be measured with sufficient reliability.
If a transaction results in a transfer of all or all future economic benefits and all or almost all risks relating to assets or liabilities to a third party, the asset or liability is no longer included on the balance sheet. Assets and liabilities are not included on the balance sheet if economic benefits are not probable and/or cannot be measured with sufficient reliability.
Revenues and expenses are allocated to the period to which they relate. Revenues are recognised when the company has transferred the significant risks and rewards of ownership of the goods to the buyer.
The financial statements are presented in euros.
Participating interests where significant influence is exercised over the business and financial policy are valued according to the net asset value. Participating interests where the company exercises control along with other participants, such as in joint ventures, are valued in the same way.
The net asset value is calculated on the basis of international financial reporting standards, thus represent approximately the fair value of the investee. Results on transactions involving transfer of assets and liabilities between the company and its participating interests and mutually between participating interests are eliminated to the extent that these cannot be regarded as having been realised.
Participating interests with a negative net asset value are stated at zero. If the company fully or partially guarantees the debts of the relevant participating interest, or if it has the constructive obligation to enable the participating interest to pay its debts (for its share therein), then a provision is recognised accordingly. This provision is recognised primarily to the debit of the receivables on the respective participating interest and for the remainder presented under provisions for the part of the share of the losses incurred by the participating interest, or for the estimated payments by the company on behalf of these participating interests.
Participating interests where no significant influence is exercised are stated at the lower of cost or realisable value. In case of a firm intention to sell, then the participating interest is stated at the lower expected sales value.
Dividends are accounted for in the period in which they are declared. Interest income is recognised in the profit and loss account on an accrual basis, using the effective interest rate method. Any profit or loss is recognised under finance income or expenses.
For tangible and intangible fixed assets an assessment is made as of each balance sheet date as to whether there are indications that these assets are subject to impairment. If there are such indications, then the recoverable value of the asset is estimated. The recoverable value is the higher of the value in use and the net realisable value. If it is not possible to estimate the recoverable value of an individual asset, then the recoverable value of the cash flow generating unit to which the asset belongs is estimated.
If the carrying value of an asset or a cash flow generating unit is higher than the recoverable value, an impairment loss is recorded for the difference between the carrying value and the recoverable value. In case of an impairment loss of a cash flow generating unit, the loss is first allocated to goodwill that has been allocated to the cash flow generating unit. Any remaining loss is allocated to the other assets of the unit in proportion to their carrying values.
In addition, an assessment is made on each balance sheet date whether there is any indication that an impairment loss that was recorded in previous years has decreased. If there is such indication, then the recoverable value of the related asset or cash flow generating unit is estimated.
Reversal of an impairment loss that was recorded in the past only takes place in case of a change in the estimates used to determine the recoverable value since the recording of the last impairment loss. In such case, the carrying value of the asset (or cash flow generating unit) is increased up to the amount of the estimated recoverable value, but not higher than the carrying value that would have applied (after depreciation) if no impairment loss had been recorded in prior years for the asset (or cash flow generating unit).
An impairment loss for goodwill is not reversed in a subsequent period, unless the previous impairment loss was caused by an extraordinary specific external event that is not expected to recur and if there are successive external events that undo the effect of the earlier event.
As a departure from the above, on each balance sheet date the recoverable value is determined for the following assets (regardless of whether there are indications of impairment):
Receivables are measured at initial recognition at fair value, plus transaction costs (if material). After initial recognition, the assets are measured at amortised cost using the effective interest method, less a provision for uncollectible debts. These provisions are determined by individual assessment of the receivables.
A deferred tax asset is recognised only to the extent that it is probable that future taxable profits will be available against which the temporary difference can be utilised.
Financial instruments taking the legal form of shareholders' equity instruments are presented under shareholders' equity. Distributions to the holders of these instruments are deducted from shareholders' equity after deduction of any related benefit related to tax on profit.
Financial instruments taking the legal form of a financial obligation are presented under loan capital. Interest, dividends, income and expenses related to these financial instruments are taken to the profit and loss account.
The share of the result of participating interests where significant influence is exercised on the business and financial policy consists of the company's share of the result of these participating interests, determined on the basis of the accounting principles of the company.
Results on transactions, with assets and liabilities being transferred between the company and the participating interests and between participating interests themselves, are not recognised as they can be deemed unrealised.
The results of participating interests acquired or sold during the financial year are stated in the company's result from the relevant acquisition date or disposal date.
Where no significant influence is exercised on the business and financial policy, dividend is accounted for in the profit and loss account as income from participating interests under finance income and expenses.
The company is the head of the group and has the capital interests listed below. Shareholders' equity and the result of the relevant interest are also stated in accordance with the latest adopted financial statements:
| Name | Legal address | Share in issued capital |
Shareholders' equity |
|
|---|---|---|---|---|
| % | EUR | EUR | ||
| Participating interests | ||||
| GRT B.V. | Pietersbergweg 283, 1105 BM, | 100 | 100 | 58,205,000 |
| Amsterdam, The Netherlands |
| Year ended December 31, | ||
|---|---|---|
| 2021 | 2020 | |
| Euros in thousands |
Euros in thousands |
|
| Balance at the beginning of the period/year | 197,882 | 159,772 |
| Addtions during the year |
52,898 | 13,149 |
| Equity in earnings of investee's | 58,205 | 24,961 |
| Balance at the end of the year | 308,985 | 197,882 |
On July 9, 2018, the Company entered into an investment agreement ("Investment Agreement") with investors (institutional and private) for a total investment of approximately EUR 82.3 million in the Company's shares at a price per share of EUR 10. According to the terms of the investment agreement, the Company "will call the money" under CAPITAL CALLS to its shareholders for all or part of the investment amounts that the shareholders undertook to invest in accordance with the investment needs of the Company subject to the resolution of the Company's board of directors; effective from the signing date of the investment agreement until the end of the second quarter of 2019 the Company has carried out CAPITAL CALLS as mentioned above and the total investment amount of € 82.3 million was fully received.
On April 18, 2019, the Company entered into an investment agreement with its existing shareholders and other private investors for an additional equity investment ("second round ") amounting to € 46.7 million in the Company's shares at a price per share of EUR 12.7, in two stages: In the first stage - the existing shareholders of the Company together with additional private investors committed to invest approximately € 20 million, and in the second stage – upon signing the investment agreement with another institutional investor to invest € 18 million in the Company's equity, existing shareholders will invest in the Company an additional amount of € 8.7 million and in total € 26.7 million in the second level.
On June 5, 2019, the investment agreement was signed with the additional institutional investor and in July the full investment consideration from all investors was received, thus completing the second round of raising capital for the Company in the gross amount of approximately € 46.7 million.
On August 5, 2020, the Company entered into an investment agreement with some of its existing shareholders and another private investor for an additional capital investment of approximately EUR 42 million in the Company's shares, at a price per share of EUR 14.45. The investment consideration from all investors was received in August 2020, thus completing the third round of raising capital for the Company in the amount of approximately EUR 42 million.
Composition of share capital: as of December 31, 2020 the authorized and issued ordinary shares of EUR 1 Cent per value each summed to 19,064,165 and 15,019,531, respectively. As of December 31, 2019 the authorized and issued ordinary shares of EUR 1 per value each summed to 19,064,165 and 12,063,612 respectively.
During the first quarter of 2020, the Company issued 50,000 ordinary shares of € 1 par value to 2 employees in exchange for € 500,000, with € 450,000 was allocated to share premium.
In addition, the Company converted the par value of all the Company's shares to EUR cent 1 per share, whereby the entire difference between EUR 1 par value per share and EUR cent 1 par value of approximately € 11,992 thousand was charged to premium.
On May 10, 2021, the Company published a shelf prospectus and a supplementary prospectus dated May 11, 2021 and the Company published a supplementary notice (above and below collectively - "the prospectus"). The securities, the subject of the prospectus, were offered by way of issuance by the Company to institutional investors, as defined in the Securities Regulations (method of offering securities to the public), 2007 ("the Offering Regulations"), by way of nonuniform offer, according to regulation 11(a)(1) of the Offering Regulations.
According to the prospectus, institutional investors were offered, by way of a non-uniform offer, 3,082,000 registered ordinary shares of EUR 0.01 par value each of the Company, at a uniform price per share in the amount of NIS 70.09, divided into 30,820 units of 100 shares each (price of each unit NIS 7,009) (the "Offering"). As part of the offering, orders were submitted to the Company for the purchase of 83,077 units, in a total amount of approx. NIS 582,287 thousand, by way of managing a BOOK BUILDING procedure out of the orders submitted as aforesaid, the Company accepted orders from institutional investors to purchase 30,820 units, including 3,082,000 shares for a total consideration of approximately NIS 216,017 thousand. On May 18, 2021, trading of the Company's shares began for the first time on the Tel Aviv Stock Exchange Ltd.
The company is in Fiscal unity for Tax purposes with its (100%) subsidiaries GRT B.V., and GRT finco B.V.
On January 18, 2022, the Company entered into a loan agreement denominated in NIS with a third party, which is an Israeli institutional entity at a total amount of EUR 60 million and for a period of 18 years.
The loan principal is due in one installment at the end of the loan period (Bullet). The Company may repay the loan by early repayment, at no additional cost, on December 31, 2028, 2031, 2034 and 2037.
The loan bears:
or more, an additional one-time payment equal to EUR 3.6 million will be paid to the lender on the final repayment date.
d. The loan is secured by a negative lien on its assets (other than real estate), and is subject to financial covenants, change of control stipulation, authority and various structure. In addition, interest rate adjustment mechanisms and grounds for early repayment have been established as acceptable in such loans. The loan was drawn down on January 20, 2022.
During the financial year, the company employed one employee for total employer cost of EUR 43,977, of it, social security contribution amounted to EUR 10,644.
As of December 31, 2021 the outstanding payroll tax and social security liability amounted to EUR 1,250; the VAT receivables amounted to EUR 130,126.
Amsterdam, October 22nd, 2022
Approved by: Nir Ilani, executive Director
In view of its size (see section 2:396(7) of the Netherlands Civil Code), the company does not have a statutory audit requirement; therefore, no audit was performed.
Under article 19.1 of the company's articles of association. The allocation of profits accrued in a financial year shall be determined by the General Meeting. If the General Meeting does not adopt a resolution regarding the allocation of the profits prior to or at latest immediately after the adoption of the annual accounts, the profits will be reserved.
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.